top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

Neurocrine Biosciences Details $2.9B Deal to Strengthen Pipeline

  • Apr 8
  • 1 min read

San Diego, CA, April 7, 2026 (Yahoo Finance) -- Neurocrine Biosciences has outlined a transaction valued at approximately $2.9 billion aimed at expanding its therapeutic portfolio. The deal is designed to enhance the company’s pipeline with additional clinical-stage assets. The move supports Neurocrine’s strategy to drive long-term growth through targeted business development initiatives.


Read full article here.

 
 
 

Recent Posts

See All

Comments


Life Science Headlines
bottom of page